Literature DB >> 4254709

Fibrinogen-fibrin breakdown products in pathologic synovial fluids. An immunologic study.

J Gormsen, R B Andersen, C Feddersen.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4254709     DOI: 10.1002/art.1780140410

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  7 in total

1.  Fibrin degradation products in rheumatoid arthritis.

Authors:  R M Bennett; A C Eddie-Quartey; P J Holt
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

2.  Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.

Authors:  E Plow; T S Edgington
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

3.  Immunofluorescent demonstration of intracellular fibrin in synovial tissue.

Authors:  R B Andersen; P Elling
Journal:  Ann Rheum Dis       Date:  1972-01       Impact factor: 19.103

4.  The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.

Authors:  H Hedberg; A B Laurell
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

5.  Amino Acid Profile of Synovial Fluid Following Intra-articular Ankle Fracture.

Authors:  Elizabeth M Leimer; Laura M Tanenbaum; Dana L Nettles; Richard D Bell; Mark E Easley; Lori A Setton; Samuel B Adams
Journal:  Foot Ankle Int       Date:  2018-08-15       Impact factor: 2.827

6.  Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage.

Authors:  E Furmaniak-Kazmierczak; T D Cooke; R Manuel; A Scudamore; H Hoogendorn; A R Giles; M Nesheim
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Investigation of synovial fluid induced Staphylococcus aureus aggregate development and its impact on surface attachment and biofilm formation.

Authors:  Matthew J Pestrak; Tripti Thapa Gupta; Devendra H Dusane; Doug V Guzior; Amelia Staats; Jan Harro; Alexander R Horswill; Paul Stoodley
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.